Browsing by Author "Barlesi, Fabrice"
Now showing items 1-4 of 4
-
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors
Barlesi, Fabrice; Isambert, Nicolas; Lee, Dae Ho; Peguero, Julio; FELIP, ENRIQUETA; Cho, Byoung Chul (Oxford University Press, 2023-03) -
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
Herbst, Roy; Majem Tarruella, Margarita; Barlesi, Fabrice; Chu, Quincy; Monnet, Isabelle; Martínez Marti, Alexandre; Carcereny, Enric (American Society of Clinical Oncology, 2022-10-10) -
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)
Ou, Sai-Hong; Nishio, Makoto; Ahn, Myung-Ju; Barlesi, Fabrice; Felip Font, Enriqueta; Mok, Tony; Zhou, Caicun (Elsevier, 2022-12) -
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
Levy, Benjamin; Barlesi, Fabrice; Paz-Ares, Luis; Bennouna, Jaafar; Erman, Mustafa; Felip Font, Enriqueta; Isla, Dolores (Elsevier, 2022-04)